Back to search
FDAFDA · Food and drugs·Recall number D-0291-2015

Fluoxetine Capsules USP, 20 mg, 100 count bottle, Rx Only, 100 Capsules, Sandoz Inc Princeton, NJ 08540 NDC 0781-2822-01

Published December 17, 2014 · Recall initiated: December 5, 2014

Summary

FDA records drug Class III recall D-0291-2015, published December 17, 2014 and initiated December 5, 2014. Recalling firm: Sandoz Incorporated; Status: Terminated; Reported quantity: 1,008 bottles; Lot: Lot ET5122, Exp. 10/17. Class III means the product is not likely to cause adverse health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Labeling: Illegible Label: Sandoz Inc. is recalling of one lot of Fluoxetine Capsules due to an illegible logo on the capsule.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Sandoz Incorporated
Distributor
AZ
Lot
Lot ET5122, Exp. 10/17
Risk classification
Class III
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Fluoxetine Capsules USP, 20 mg, 100 count bottle, Rx Only, 100 Capsules, Sandoz Inc Princeton, NJ 08540 NDC 0781-2822-01 recalled?

Yes. FDA published recall D-0291-2015 on December 17, 2014. Reported hazard: Labeling: Illegible Label: Sandoz Inc. is recalling of one lot of Fluoxetine Capsules due to an illegible logo on the capsule.

What should I do if I have this product?

Voluntary: Firm initiated · Letter